Race for better lupus treatment: drug trial halted early
Disease control
Terminated
This study tested whether a new drug called telitacicept could help control moderate-to-severe lupus symptoms better than a placebo. It involved 91 patients aged 12-70 who continued their standard lupus medications. The trial was terminated early, so the full results are not avai…
Phase: PHASE3 • Sponsor: Vor Biopharma • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC